The Absorption Gap
Buckwheat honey scores 14× higher than acacia on ORAC — the standard antioxidant capacity assay. But ORAC measures free-radical scavenging in a test tube, not what your gut absorbs. Break the gap down by compound class, apply published absorption rates, and the ratio compresses — but the ranking order mostly survives. Here is what the math actually shows.
ORAC: Gheldof & Engeseth (2002); Bertoncelj et al. (2007). Bioavailability: Stalmach et al. (2010); Manach et al. (2004); Hollman & Katan (1999). In-vivo critique: Lotito & Frei (2004). See methodology.
The 14× test-tube ORAC gap between buckwheat and acacia honey compresses to approximately 10–11× once you account for compound-class bioavailability. The ranking order is largely preserved: buckwheat is still clearly the highest-antioxidant honey per gram absorbed. The bigger lesson is compound class: heather honey scores 490 ORAC but its dominant flavanones (pinocembrin, galangin) are absorbed at only 1–10%, meaning its effective systemic antioxidant delivery is far lower than its ORAC rank implies.
What the absorption math actually says
ORAC (Oxygen Radical Absorbance Capacity) measures how quickly a substance donates hydrogen atoms to neutralize peroxyl radicals in a fluorescence-decay assay. It is an excellent in-vitro tool for ranking honey varieties against each other. It says nothing about what fraction of phenolics crosses the gut wall intact, survives first-pass metabolism, and reaches plasma in active form.
Est. bioavailable ORAC = ORAC × bioavailability_fraction where bioavailability_fraction ∈ [0.01, 0.33] depending on dominant compound class
Bioavailability fraction is a compound-class mean systemic absorption estimate from ileostomy and pharmacokinetic studies (Stalmach et al. 2010; Manach et al. 2004). It is NOT a honey-specific measurement — individual variation (gut microbiome) can shift results ±50%.
The chart below places the same 7 varieties side-by-side: left bars show raw ORAC; right bars show estimated bioavailable ORAC using each variety’s dominant compound-class absorption rate. Row order is locked to ORAC ranking so the visual compression is immediately legible.
ORAC vs estimated bioavailable ORAC — 7 varieties
Left panel: test-tube ORAC (μmol TE/100 g). Right panel: ORAC × mean absorption % for dominant phenolic class. Sorted by ORAC (highest first).
Bioavailable ORAC = ORAC × mean absorption % for dominant compound class. Absorption ranges: phenolic acids 25–33% (Stalmach et al. 2010); flavonol glycosides 20–30% (Hollman & Katan 1999); flavanones 1–10% (Manach et al. 2004). Individual variation ±50% due to gut microbiome. See methodology.
Compound class determines what your gut absorbs
The key variable is not ORAC score alone — it is the phenolic compound class that dominates a variety’s profile. Two honeys can have similar ORAC but radically different bioavailability because their dominant compounds are from different classes.
Best-studied class for honey. Survive small intestine intact; absorbed into portal vein. Buckwheat chlorogenic acid data comes from extensive coffee research (same compound, same dose range).
Moderate absorption. Gut microbiome hydrolysis of glucosides is rate-limiting. Individual variation (microbiome composition) creates ±50% person-to-person spread.
Poor oral bioavailability. Low aqueous solubility, high intestinal conjugation. This is the key hidden limitation of high-ORAC honeys dominated by propolis-derived flavanones.
Food matrix matters significantly — tannin binding to dietary proteins and honey's natural protein content can reduce effective dose.
Heather honey scores 490 ORAC — higher than many dark honeys. Its dominant phenolics are pinocembrin and galangin, both propolis-derived flavanones. These compounds are among the least bioavailable phenolics known: 1–10% systemic absorption after oral dosing (Manach et al. 2004). Applied to heather’s ORAC, that yields an estimated bioavailable fraction of 5–49 μmol TE per 100 g — overlapping with clover and acacia, despite a 6× raw ORAC advantage. This does not make heather honey “bad” — its thixotropic texture, minerality, and phenolic complexity have other culinary value. It does mean heather should not be purchased specifically for antioxidant intake.
Variety breakdown: dominant compound, absorption range, and note
| Variety | ORAC | Dominant compound | Absorption range | Est. bio-ORAC |
|---|---|---|---|---|
| Buckwheat | 796 | Chlorogenic acid | 25%–33% (mid 30%) | ~239 |
| Chestnut | 620 | Catechins (condensed tannins) | 20%–40% (mid 30%) | ~186 |
| Heather | 490 | Pinocembrin + galangin | 1%–10% (mid 5%) | ~25 |
| Wildflower | 290 | Mixed (quercetin, kaempferol, chlorogenic) | 18%–30% (mid 24%) | ~70 |
| Manuka | 215 | Leptosperin (methylsyringate) | 20%–35% (mid 27%) | ~58 |
| Clover | 80 | Kaempferol + quercetin (low) | 18%–28% (mid 22%) | ~18 |
| Acacia | 55 | Kaempferol (trace) | 15%–28% (mid 21%) | ~12 |
ORAC: μmol TE / 100 g honey (Gheldof & Engeseth 2002; Bertoncelj et al. 2007). Est. bio-ORAC = ORAC × mid absorption %. Absorption rates are compound-class means from human pharmacokinetic studies; individual variation ±50% due to gut microbiome differences. Does not account for food-matrix effects specific to honey.
The in-vivo challenge: uric acid and the ORAC overclaim
Lotito and Frei (2004, Free Radical Biology & Medicine) published a finding that unsettled the ORAC extrapolation model: a large fraction of the plasma antioxidant capacity increase seen after consuming high-ORAC foods is attributable not to absorbed polyphenols but to a metabolic response — increased uric acid production from fructose metabolism.
Honey is rich in fructose (37–43% of mass). When you eat a tablespoon of buckwheat honey, the fructose drives uric acid production, which temporarily elevates plasma antioxidant capacity. This is measured as “improved antioxidant status” in short-term plasma assays — but uric acid is not the same as phenolic-derived antioxidant protection, and chronic uric acid elevation has its own health implications (gout, urate crystals).
The practical implication: studies measuring “plasma antioxidant capacity after honey consumption” may be partly or largely measuring the uric acid response rather than phenolic absorption. This makes it difficult to cleanly credit honey’s phenolics with health effects measured in blood antioxidant panels.
- It does not mean honey polyphenols have no effect. Chlorogenic acid has demonstrated bioavailability and cardiovascular effects in its own right (independent of ORAC assays).
- It does not mean all ORAC research is invalid. ORAC is a valid comparative assay for ranking varieties relative to each other in controlled conditions.
- It does not mean buckwheat honey is not the best antioxidant choice among honeys — it still is, by any measure.
- It means the clinical translation from ORAC → health benefit requires more than the assay number alone, and health claims must be hedged accordingly.
Practical guide: which honey, and when, if antioxidants matter to you
| Goal | Best honey choice | Why |
|---|---|---|
| Maximum antioxidant intake per gram | Buckwheat | Highest ORAC and highest bioavailable fraction (chlorogenic acid, 25–33% absorbed) |
| Best antioxidant value per dollar | Buckwheat | ~187 raw ORAC per dollar (Dutch Gold at ~$9/16oz); see antioxidant value index |
| Antibacterial action (topical/clinical) | Manuka (UMF 10+) | MGO pathway is orthogonal to ORAC — the phenolic antioxidant ranking does not predict antibacterial potency |
| Polyphenol-rich honey with high food appeal | Chestnut | 620 ORAC + catechins with 20–40% bioavailability + distinctive bitter-earthy flavor that most high-ORAC honeys lack |
| Neutral flavor + low GI (antioxidants not priority) | Acacia | GI 32, stable liquid, mild — valued for properties other than phenolics |
| Context: actual antioxidant-dense foods | Blueberries, blackcurrants, dark chocolate | Half-cup blueberries ≈ 3,200 ORAC — ~20× more than a tablespoon of buckwheat honey. Honey as sweetener-substitute, not antioxidant supplement |
What this data story does NOT claim
- It does not say honey cures or prevents any disease. The evidence for honey as a therapeutic agent is primarily wound-care (manuka MGO) and cough-suppression (raw honey in children). Polyphenol bioavailability data does not translate to clinical disease prevention claims.
- It does not use compound-specific honey-matrix bioavailability data, because that research largely does not exist. Chlorogenic acid bioavailability from buckwheat honey has not been measured in human ileostomy studies — only from coffee solutions at similar dose ranges. The honey-matrix effect (fructose slowing gastric emptying; honey pH; protein interactions) is an acknowledged assumption.
- It does not cover Meliponini (stingless bee) honey. Kelulut, jatai, and Melipona honeys have different phenolic profiles including abscisic acid and unique flavonoids not covered by the Gheldof & Engeseth or Bertoncelj datasets.
- It does not account for synergistic effects. Phenolics in whole food matrices may interact synergistically with honey proteins, enzymes, and oligosaccharides in ways not captured by single-compound bioavailability studies.
Frequently asked questions
If ORAC doesn't translate to in-vivo benefit, why does it matter at all?
Which honey compounds are best absorbed?
Does pasteurization destroy honey antioxidants?
How does honey's antioxidant content compare to fruits and vegetables?
Why is heather honey's antioxidant profile considered overestimated?
Does the honey matrix affect antioxidant absorption?
Keep reading
Raw Honey Guide Editorial Team
Reviewed by certified beekeepers and apiculture specialists. Our editorial team consults with professional beekeepers, food scientists, and registered dietitians to ensure accuracy. Health claims are cited against peer-reviewed literature from Cochrane, JAFC, BMJ, and Nutrients.